Sonida Senior Living (SNDA): Priced In on Deal Hopes, Improving Beneath the Noise

On March 11, 2026, Sonida Senior Living closed a $1.8 billion stock-and-cash merger with CNL Healthcare Properties — roughly tripling its quarterly revenue to $207.6 million by the second quarter and turning it into the eighth-largest owner of U.S. senior housing assets. The stock's bull case is that this is only a first step: management has touted an $88 million acquisition pipeline and a strategy built around continued buying at "attractive price points". The question the market keeps asking is whether Sonida is a bargain or whether the deal expansion is already in the price.

The factor stack says the second one. This is not an obviously cheap stock, because it does not yet earn an obvious profit.

The bargain case falls apart on the multiple

Start with the valuation, because that is where "bargain" gets defined. Sonida trades at roughly 3.4 times trailing sales, 2.1 times book, and an enterprise value of about $3.3 billion against a $1.8 billion market cap — the gap between the two is $1.5 billion of net debt. Earnings are negative: trailing P/E is a loss, and forward expectations still pencil in losses through 2026. There is no dividend, so a yield investor gets no income while waiting.

The multiple that gets quoted — roughly 165 times trailing EV/EBITDA — is itself mostly an arithmetic artifact. Trailing EBITDA margins sit near zero, so dividing enterprise value by a near-zero denominator produces a number that means little on its own. But the honest translation of that artifact is the point: before synergies do their work, Sonida generates almost no cash EBITDA against a heavy debt load. Conventional cheap screens simply do not apply to a business in this state.

Put it beside senior-housing peers that actually make money. Welltower carries an EV/EBITDA of about 64 times and Ventas about 25 times — both far lower multiples, both profitable, both paying dividends. Whatever Sonida is, a relative-value screen does not flag it as the cheap one in the room.

The growth headline is deal arithmetic

The revenue growth that makes the story look explosive — up about 49% year over year, 69% quarter over quarter — is merger accounting, not organic compounding. When you buy a portfolio the size of CNL's and consolidate it, revenue jumps overnight regardless of how the underlying assets perform. Reading that as organic growth is the classic misleading comparison, and it is exactly what the "bargain" framing leans on.

That does not mean there is nothing real underneath. The operating report card, as opposed to the headline, is genuinely improving: weighted-average occupancy reached 87.8% in the second quarter, a 240-basis-point gain from a year earlier; same-store net operating income rose 16.9%; adjusted EBITDA was up roughly 30%; and labor costs fell to a portfolio-low 40.4% of revenue as agency usage came down. A stock moving from weak to decent is often more actionable than a former top scorer eroding — the improvement is the signal to follow.

The balance sheet is the honest brake

What keeps this from being an unqualified quality story is the safety factor. Sonida carries $1.5 billion of net debt, debt-to-equity at roughly 1.8, free cash flow of about negative $91 million over the trailing year, and just under $49 million of cash on hand. The CNL deal added a $270 million bridge loan that must be refinanced into property-level financing before it matures. Interest coverage at these numbers is thin, and the whole thesis leans on the new revenue stream converting into cash flow faster than the debt service demands it.

Momentum adds a cautionary tone rather than confirmation. The stock is up about 16% year to date and about 46% over the trailing year, but it trades below its 50-day average with a 14-day RSI near 42 — positive over the longer run, stalled over the short term, after pulling back about 6% in the past month. AInvest's aggregate signal labels the shares Buy, but an opaque scorecard does not change what the underlying factor stack shows: real operating momentum on top of a leveraged, still-unprofitable base.

What the numbers say to do

So the honest answer to "bargain or priced in" is that the deal expansion is priced in — investors are paying a rich multiple today for operating leverage, synergies, and further accretive buying that have yet to show up in cash earnings. The improvement story is real but early, and it is happening on a balance sheet with little room for error.

That tells you the portfolio role, not just the rating. This is not the durable cash-flow leg of a barbell — there is no dividend, negative margins, and high leverage, so it does not hedge anything and it gets hurt in a risk-off regime. It belongs, if at all, in a small high-risk sleeve as a bet on operating leverage and continued deal execution. The trigger that would change the read is conversion: sustained same-store NOI growth and occupancy that finally translate into positive free cash flow and a credible EBITDA multiple. Until those arrive, the dozens of "cheap"-looking growth numbers are a story about hopes, not about earnings.